Indian pharma should maintain facilities better: Kewal Handa
In coversation with NDTV Profit, pharma expert Kewal Handa shares his thoughts about the recent USA FDA 'warning letters' & 'import alert' for Indian companies and how Indian pharma should be more pro-active in maintaining facilities
![Gadgets 360 With Technical Guruji: Ask TG [February 22, 2024]](https://c.ndtvimg.com/2025-02/dtk1rko_ask-tg_160x120_22_February_25.jpg?downsize=355∶533 "Gadgets 360 With Technical Guruji: Ask TG [February 22, 2024]")
